TLDR: Reveal HealthTech, a specialist in AI transformation for the U.S. healthcare and life sciences sectors, has successfully closed a $7.2 million Series A funding round. Led by Leo Capital with participation from Sanos Capital, this investment will fuel the expansion of its AI-powered solutions, including BioCanvas and Prism AI, and strengthen its global market presence. The company, founded in 2023, aims to make AI a trusted partner in healthcare by optimizing clinical workflows and improving patient outcomes.
Reveal HealthTech, a prominent AI transformation partner for U.S. healthcare and life sciences companies, has announced the successful completion of its $7.2 million Series A funding round. The investment was spearheaded by Leo Capital, with additional participation from Sanos Capital. Existing investors, W Health Ventures and 2070 Health, who incubated the company since its founding in 2023, also reaffirmed their commitment.
The company has rapidly established itself as a ‘healthcare AI specialist,’ operating at the critical intersection of advanced artificial intelligence and profound healthcare expertise. Reveal HealthTech’s core mission is to assist healthcare organizations in identifying their most impactful challenges and developing secure, clinically relevant AI systems to address them.
Dr. Sumir Sahgal, founder and Chief Medical Officer of Essen Health Care, a New York-based integrated healthcare delivery network, emphasized the transformative potential of Reveal’s work. “Every year, across hundreds of thousands of patient touchpoints, we’ve seen the profound impact that compassion and intelligence can have when woven into care. At Essen Health Care, we have long envisioned what it would mean if every interaction reflected empathy and personalization. With Reveal, that vision is becoming reality. By acting on data in real-time, we’re not only improving patient experiences but also easing the burden on clinicians,” he stated.
AI is no longer a peripheral concept in healthcare; it is fundamentally reshaping diagnostics, treatment delivery, and operational efficiencies. Reveal HealthTech positions itself as a key catalyst in this AI adoption, backed by a world-class team boasting academic excellence from institutions like MIT, Harvard Medical, and UC Berkeley, alongside extensive technology innovation experience from organizations such as Boston Children’s, Mass General, SpaceX, NASA, Athena Health, and Infosys.
Sanchit Mullick, Founder of Reveal HealthTech, articulated the company’s ambitious vision: “Our mission is simple but bold. We want to make AI the most trusted and accountable partner in healthcare, driving breakthroughs for everyone from Fortune 100 pharma companies and large healthcare delivery systems to emerging innovators in digital health.”
Reveal’s solutions are designed to enhance customer value and boost the profitability of healthcare operations. Its flagship offerings include: BioCanvas: This platform facilitates multimodal AI use cases, such as accelerating clinical trial recruitment through advanced AI analysis. Prism AI: This solution enables the rapid development of intelligent agents for workflow automation within healthcare settings.
The company has already demonstrated tangible impact. In a recent deployment for a $40 billion U.S. medical device leader, Reveal successfully improved patient adherence through AI-driven data integration, establishing a reusable blueprint for future clients. Mullick noted that a predictive model developed in this case improved patient adherence by 10 to 15 percent, leading to better outcomes in chronic disease management.
Mullick highlighted that their approach leverages the “gold mine of digital data” accumulated over two decades of electronic health record (EHR) implementations in the U.S. He clarified that the company’s goal is not to replace doctors but to reimagine and streamline clinical workflows, emphasizing that “AI in healthcare is often equated with clinical decision support. But that’s just a sliver of the opportunity. We are using AI to amplify and streamline clinical workflows.”
Rajul Garg, Partner at Leo Capital, praised the team’s unique capabilities: “Meeting with Sanchit, Dr Salim, and the AI leadership team at Reveal made it clear their superpower lies in crafting tailored solutions that demonstrate time-bound, business goodness to clients. We’re very excited to support the team in its next phase of growth.” Dr. Pankaj Jethwani, Managing Partner at W Health Ventures, added, “Healthcare cannot be solved with one-size-fits-all point solutions. Reveal understands that nuance, which is why we backed them from day one. We see an incredible opportunity for Reveal to support the rapid AI adoption within the US healthcare industry.”
Also Read:
- AmplifAI Secures $33.7 Million Series B to Advance AI-Powered Customer Experience and Workforce Optimization
- Rehuman, an AI InsurTech, Raises £1 Million in Pre-Seed Funding Led by Fuel Ventures
The Series A funding will enable Reveal HealthTech to expand its capabilities and solutions, strengthen its sales network, and extend its reach to a broader spectrum of healthcare and life sciences leaders globally. The company currently maintains a workforce of approximately 120 individuals across the U.S. and India, with leadership based in the U.S. and a dedicated development team in Bengaluru. As part of its strategic growth, Reveal HealthTech has also joined the Cipher Collective, an ECG-powered AI partner network committed to transforming care delivery through best-in-class health technology solutions.
